TCL Archive Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not? April 25, 2013
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Letters to the Editor: Us Too! Objects to ODAC Member’s Comments; Brawley Responds March 28, 2003
